Drug Shortage Report for MAXALT RPD

Last updated on 2019-03-02 History
Report ID 64443
Drug Identification Number 02240518
Brand name MAXALT RPD
Common or Proper name rizatriptan benzoate wafers
Company Name MERCK CANADA INC
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 12wafers
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-11-09
Actual start date 2018-11-02
Estimated end date 2019-03-01
Actual end date 2019-03-01
Shortage status Resolved
Updated date 2019-03-02
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2019-03-02 English Compare
v18 2019-03-01 French Compare
v17 2019-03-01 English Compare
v16 2019-02-26 French Compare
v15 2019-02-26 English Compare
v14 2019-02-19 French Compare
v13 2019-02-19 English Compare
v12 2019-02-07 French Compare
v11 2019-02-07 English Compare
v10 2019-01-28 French Compare
v9 2019-01-28 English Compare
v8 2018-12-12 French Compare
v7 2018-12-12 English Compare
v6 2018-11-03 English Compare
v5 2018-11-02 French Compare
v4 2018-11-02 English Compare
v3 2018-10-16 French Compare
v2 2018-10-16 English Compare
v1 2018-10-16 English Compare